Amniotic Membrane Market Overview
The Amniotic Membrane Market size is estimated to reach $1.15 billion by 2027 and is poised to grow at a CAGR of 7.8% over the forecast period of 2022-2027. The amniotic membrane is an avascular fetal membrane, which lies deep down the chorion, and is usually harvested in a sterile environment, particularly from the placental tissue in the cesarean procedures. After opting for the following procedure, the elected donor is screened for transmissible diseases, following which amnion is treated with a broad spectrum of antibiotics. The amnion is made up of three layers- epithelium, basement membrane, and lastly, the stroma. Furthermore, amniotic membrane transplantation is widely used as a graft in various surgeries, making it of utmost use in the field of ophthalmology. Moreover, membrane transplantation is being used in various subspecialties. Additionally, technologies such as PROKERA are being rapidly made accessible to the world around. It is a medical device used to protect, repair, and even heal damaged surfaces of the eyes. Owing to a surge in the R&D-related activities in stem cell and regenerative medicine along with the properties of amniotic membrane in reducing pain and improving the healing process are some of the factors driving the Amniotic Membrane Industry forward in the forecast period.
Report Coverage
The report: “Amniotic
Membrane Market Forecast (2022-2027)", by Industry ARC covers an in-depth
analysis of the following segments of the Amniotic Membrane Market.
By Type- Cryopreserved Amniotic Membrane and
Dehydrated Amniotic Membrane.
By Application- Ophthalmology, Surgical Wounds Repairment,
and Others.
By End-Users- Hospitals, Ambulatory Surgical Centers,
Private Clinics, and Others.
By
Geography- North America (U.S., Canada, Mexico), Europe (Germany,
United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia
Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest
of Asia Pacific), South America (Brazil, Argentina, and Rest of South America),
and Rest of the World (the Middle East, and Africa).
Key Takeaways
- Geographically, North America’s amniotic membrane market held a dominant market share in the year 2021. It is owing to an increase in the healthcare expenditure supplemented by the rising R&D investments across the new ventures. And lastly, a surge in the ASCs has aided the market hold. Moreover, Asia-Pacific is estimated to offer lucrative growth opportunities to the marketers owing to an increase in the geriatric population and their need for having eye surgeries.
- An increase in the cases of ophthalmic surgeries supplemented with old age is the key market driver. However, the side effects post surgeries have impeded the market growth.
- A detailed analysis of strengths, weaknesses, opportunities,
and threats will be provided in the Amniotic Membrane Market Report.
Amniotic Membrane Market- Geography (%) for 2021
For More Details on This Report - Request for Sample
Amniotic Membrane Market Segmentation Analysis - By Type
The amniotic membrane
market based on type can be further segmented into Cryopreserved Amniotic
Membrane and Dehydrated Amniotic Membrane. Cryopreserved Amniotic Membrane held
a dominant market share in the year 2021. The cryopreservation technique is
based on slow-freezing, usually at -80 degrees, thereby also using DMEM or
glycerol, to not form ice. Owing to the following technique, it retains
extracellular matrix components, such as heavy-chain hyaluronic acids, growth
factors, fibronectin, and collagen, all of which promote anti-inflammatory
effects and healing.
Moreover, the cryopreserved amniotic membrane segment is estimated to be the fastest-growing, with a CAGR of 8.4% over the forecast period of 2022-2027. It is owing to the predominant product launches and advances being made in the following segment. The cryopreserved amniotic membrane is obtained from the C-sections, whose numbers are growing. The worldwide C-sections procedure has zoomed from 7% in 1990 to 21% in 2021, and WHO predicts for it to rise in the coming decades, thereby facilitating the overall growth of the market.
Amniotic Membrane Market Segmentation Analysis - By Application
The amniotic membrane
market based on the application can be further segmented into Ophthalmology,
Surgical Wounds Repairment, and Others. The ophthalmology segment held a
dominant market share in the year 2021. It is owing to its properties that
initiate a faster recovery time, while also substantially reducing the
inflammation. Moreover, the amniotic membrane is also used to reduce scarring
and post-operative eye cohesion stress. Additionally, the geriatric population
is highly susceptible to having eye-related ailments, and the population of
seniors in the demographic is increasing. For example, as per US CDC, the
demographic demarcation of the seniors is growing, and by 2030, their segment
would weigh close to 22%, which for now is 16%.
Additionally, the ophthalmology segment is estimated to be the fastest-growing, with a CAGR of 8.5% over the forecast period of 2022-2027. It is owing to a range of product innovations and discoveries stemming from the research in regenerative medicines, which will allow for better usage of amniotic membranes in the said segment.
Amniotic Membrane Market Segmentation Analysis - By Geography
The amniotic membrane
market based on geography can be further segmented into North America, South
America, Europe, Asia-Pacific, and the rest of the World. North America’s
amniotic membrane held a dominant market share of 39% as compared to the other
regions. It is owing to the region’s superior position in launching better
products, which allows for the use in multiple applications. Additionally, the
US government spent close to 5% or $175 billion in 2018 only for R&D in
medical systems. Owing to such strategies and reimbursement policies under medical
insurances, the market held a significant position.
However, Asia-Pacific is estimated to offer lucrative growth opportunities to marketers. It is owing to the surge in medical inventions, predominantly seen in the countries such as Korea, Japan, China, and India. Moreover, India saw an incremental budget allotment of 137% as compared to the previous year, to enhance the overall medical infrastructure. Owing to better policies and an improved outlook, the market is expected to grow at a steadfast pace in the projected period of 2022-2027.
Amniotic Membrane Market Drivers
The use of sutureless AMs in promoting and healing ocular surface conditions has readily aided the market growth
The use of sutureless technology has the potential to promote the overall healing process of the surface conditions which have stemmed owing to corneal scarring and people not responding to other treatments. For example, Keratitis, an inflammatory condition of the cornea which covers the pupil and iris can be created from infectious sources and non-infectious sources. In the case of the former, an antibiotic treatment course is recommended, however, in the case of the latter the keratitis can be created owing to contact lens overwear, auto-immune disease, and even dry-eye. The auto-immune keratitis most commonly occurs in patients suffering from rheumatoid arthritis. In the US, out of every 100,000 people, 71 are diagnosed with the following arthritis form, additionally, 1.5 million Americans have rheumatoid arthritis. Neurotrophic keratitis is again a serious condition, which can be caused by corneal nerve damage. Moreover, the former form is a result of a trauma or herpetic infection. Further, the following form of keratitis can be of utmost difficulty to handle. Hence, early intervention of AM can be used to facilitate faster wound healing and avoid complications such as corneal meal or even scar formation.
The growing number of ASCs has readily supplemented the market growth
ASCs or Ambulatory Surgical
Centers have been growing in numbers for over a decade. In 2010, there were
close to 5000 ASCs in the states of the US, however, they have now zoomed to
around 10,000. The Medicare which is certified by ASCs, particularly in ophthalmology
stands at the position of three, only after “orthopedic” and “pain.”
Substantially, in a single specialty ASCs, a share of 25% is being kept
reserved by the ophthalmology department. Since the geriatric population is
more susceptible to having ocular diseases, the ASCs have bloomed. Moreover,
the senior population prefers the following setup for any procedures as they
are cost-sensitive, allow the patient to return on the same day, and also the
chances of catching an SSIs are relatively low. Lastly, the government of the
US plans to save around $22 billion by the use of ASC, under the American
Rescue Plan, moreover, the Association of ASCs predict that they can help the
Medicare program in saving up to $58 billion over the next decade. Owing to such
parameters, the market is estimated to grow.
Amniotic Membrane Market Challenges
The post-operative challenges have been a market growth dampener
The use of AMs has been of
excessive use in the medical field, particularly in, ophthalmology for more than
decades, there have been cases where postoperative complications. Corneal
abrasions might arise from the lid speculum, forceps, or a very aggressive
application or removal of an older version of cryopreserved AM. Moreover,
patients might report an increased foreign body sensation and even discomfort
which can range from severe to mild. Poor Cornea-contract lens relationship can
make the overall application of AM unsuccessful. If a contracting lens is too
tight it can cause impingement of the limbal stem cell region, which can
exacerbate issues with a healing corneal epithelium. Owing to such
disadvantages, the market faces a ready market challenge.
Amniotic Membrane Industry Outlook
Product launches, mergers and acquisitions, joint ventures,
and geographical expansions are key strategies adopted by players in this market. Amniotic
Membrane top 10 companies include:
- Amnio Technology LLC
- Celularity Inc.
- Human Regenerative Technologies LLC
- Katena Products Inc.
- MiMedx
- Integra LifeSciences Corporation
- Skye Biologics Inc.
- Amniox Medical Inc.
- Smith And Nephew
- Life Cell International Pvt Ltd.
Recent Developments
- In November 2021, MIMEDX demonstrated that its dehydrated human amnion chorion membrane usually outperforms the standard care in select Mohs defect reconstructions. The product- PURION, has an associated lower risk of SSIs, poor scar cosmesis, scar revision, and additional operation at the index site when compared to other incisional repairs. Mohs micrographic surgeries are increasing in number owing to an increase in the cutaneous malignancies in the aged population.
- In May 2021, MIMEDX announced a collaborative agreement with Wake Forest Institute Regenerative Medicines. The collaboration focus to develop synergy between the companies shared vision of advancing the use of amniotic membranes in making regenerative medicines. Further, advance scientific evidence in support of safe and effective clinical therapies and restore quality of life for patients and is geared to further understanding product mechanisms of action and potential therapeutic targets.
- In February 2020, Integra Life-Sciences Holding Corporation launched its Amnio-Excel Plus Placental Allograft Membrane. It is the latest addition to help in repairing any soft-tissue repair procedure. AmnioExcel Plus is a next-generation, thicker, tri-layer, non-side-specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds. The proprietary DryFlex processing technology preserves the inherent growth factors, cytokines, and extracellular matrix (ECM) found in native placental tissue.
Relevant Titles
Eye
Infections Treatment Market- Forecast (2022-2027)
Report Code- HCR 0209
Eye
Drop Lubricants Market-Forecast (2022-2027)
Report Code- HCR 94497
For more Lifesciences and Healthcare related reports, please click here
LIST OF TABLES
1.Global Amniotic Membrane Market By Product Market 2023-2030 ($M)1.1 Cryopreserved Amniotic Membrane Market 2023-2030 ($M) - Global Industry Research
1.2 Lyophilization Amniotic Membrane Market 2023-2030 ($M) - Global Industry Research
2.Global Amniotic Membrane Market By End-User Market 2023-2030 ($M)
2.1 Hospital Market 2023-2030 ($M) - Global Industry Research
2.2 Ambulatory Surgical Center Market 2023-2030 ($M) - Global Industry Research
2.3 Specialized Clinic Market 2023-2030 ($M) - Global Industry Research
2.4 Research Center Laboratory Market 2023-2030 ($M) - Global Industry Research
3.Global Amniotic Membrane Market By Product Market 2023-2030 (Volume/Units)
3.1 Cryopreserved Amniotic Membrane Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Lyophilization Amniotic Membrane Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Amniotic Membrane Market By End-User Market 2023-2030 (Volume/Units)
4.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Ambulatory Surgical Center Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Specialized Clinic Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Research Center Laboratory Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Amniotic Membrane Market By Product Market 2023-2030 ($M)
5.1 Cryopreserved Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
5.2 Lyophilization Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
6.North America Amniotic Membrane Market By End-User Market 2023-2030 ($M)
6.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
6.2 Ambulatory Surgical Center Market 2023-2030 ($M) - Regional Industry Research
6.3 Specialized Clinic Market 2023-2030 ($M) - Regional Industry Research
6.4 Research Center Laboratory Market 2023-2030 ($M) - Regional Industry Research
7.South America Amniotic Membrane Market By Product Market 2023-2030 ($M)
7.1 Cryopreserved Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
7.2 Lyophilization Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
8.South America Amniotic Membrane Market By End-User Market 2023-2030 ($M)
8.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
8.2 Ambulatory Surgical Center Market 2023-2030 ($M) - Regional Industry Research
8.3 Specialized Clinic Market 2023-2030 ($M) - Regional Industry Research
8.4 Research Center Laboratory Market 2023-2030 ($M) - Regional Industry Research
9.Europe Amniotic Membrane Market By Product Market 2023-2030 ($M)
9.1 Cryopreserved Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
9.2 Lyophilization Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
10.Europe Amniotic Membrane Market By End-User Market 2023-2030 ($M)
10.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
10.2 Ambulatory Surgical Center Market 2023-2030 ($M) - Regional Industry Research
10.3 Specialized Clinic Market 2023-2030 ($M) - Regional Industry Research
10.4 Research Center Laboratory Market 2023-2030 ($M) - Regional Industry Research
11.APAC Amniotic Membrane Market By Product Market 2023-2030 ($M)
11.1 Cryopreserved Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
11.2 Lyophilization Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
12.APAC Amniotic Membrane Market By End-User Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Ambulatory Surgical Center Market 2023-2030 ($M) - Regional Industry Research
12.3 Specialized Clinic Market 2023-2030 ($M) - Regional Industry Research
12.4 Research Center Laboratory Market 2023-2030 ($M) - Regional Industry Research
13.MENA Amniotic Membrane Market By Product Market 2023-2030 ($M)
13.1 Cryopreserved Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
13.2 Lyophilization Amniotic Membrane Market 2023-2030 ($M) - Regional Industry Research
14.MENA Amniotic Membrane Market By End-User Market 2023-2030 ($M)
14.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
14.2 Ambulatory Surgical Center Market 2023-2030 ($M) - Regional Industry Research
14.3 Specialized Clinic Market 2023-2030 ($M) - Regional Industry Research
14.4 Research Center Laboratory Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Amniotic Membrane Market Revenue, 2023-2030 ($M)2.Canada Amniotic Membrane Market Revenue, 2023-2030 ($M)
3.Mexico Amniotic Membrane Market Revenue, 2023-2030 ($M)
4.Brazil Amniotic Membrane Market Revenue, 2023-2030 ($M)
5.Argentina Amniotic Membrane Market Revenue, 2023-2030 ($M)
6.Peru Amniotic Membrane Market Revenue, 2023-2030 ($M)
7.Colombia Amniotic Membrane Market Revenue, 2023-2030 ($M)
8.Chile Amniotic Membrane Market Revenue, 2023-2030 ($M)
9.Rest of South America Amniotic Membrane Market Revenue, 2023-2030 ($M)
10.UK Amniotic Membrane Market Revenue, 2023-2030 ($M)
11.Germany Amniotic Membrane Market Revenue, 2023-2030 ($M)
12.France Amniotic Membrane Market Revenue, 2023-2030 ($M)
13.Italy Amniotic Membrane Market Revenue, 2023-2030 ($M)
14.Spain Amniotic Membrane Market Revenue, 2023-2030 ($M)
15.Rest of Europe Amniotic Membrane Market Revenue, 2023-2030 ($M)
16.China Amniotic Membrane Market Revenue, 2023-2030 ($M)
17.India Amniotic Membrane Market Revenue, 2023-2030 ($M)
18.Japan Amniotic Membrane Market Revenue, 2023-2030 ($M)
19.South Korea Amniotic Membrane Market Revenue, 2023-2030 ($M)
20.South Africa Amniotic Membrane Market Revenue, 2023-2030 ($M)
21.North America Amniotic Membrane By Application
22.South America Amniotic Membrane By Application
23.Europe Amniotic Membrane By Application
24.APAC Amniotic Membrane By Application
25.MENA Amniotic Membrane By Application
26.Alliqua Biomedical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Amnio Technology, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Applied Biologics Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Fziomed Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Human Regenerative Technologies, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Integra Lifesciences Holding Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Katena Products, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Mimedx Group Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Skye Biologics Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Tissue-Tech Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)